Improving Walking in Peripheral Artery Disease
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- Omaha, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 10 people enrolled
- Started
- 1 Oct 2021
- Ended
- 30 Sept 2024
- Type of study
- Interventional
- Treatments tested
- Assistive tennis shoes
- Record updated
- 31 October 2025
Who can take part
- Age
- 40 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- At entry into the study, all patients must:
- be able to give written, informed consent
- demonstrate positive history of chronic claudication
- have an ankle brachial index < 0.90 at rest
- have a stable blood pressure regimen, stable lipid regimen, stable diabetes regimen and risk factor control for 6 weeks
Who cannot take part
- rest pain or tissue loss due to peripheral artery disease (Fontaine stage III and IV)
- acute lower extremity ischemic event secondary to thromboembolic disease or acute trauma
- walking capacity significantly limited by conditions other than claudication including leg (joint/musculoskeletal, neurologic) and systemic (heart, lung disease) pathology
- Any potential subjects will be excluded if they have:
Where in United States
- Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NEOmaha, United States
About the trial
What the trial wants to find out
Peripheral artery disease (PAD) is a cardiovascular disease manifesting from systemic atherosclerosis that blocks the leg arteries and results in insufficient blood flow to the lower extremities. Limb ischemia from PAD is the most common disorder treated within the vascular surgical service of the Omaha Veterans Affairs Medical Center. PAD also accounts for one-third of the operations performed in the VA Medical Centers nationwide. The risk of mortality of Veterans with PAD is substantial; nearly 30% of Veterans with PAD died within 3.8 years of diagnosis. This project aims to establish the feasibility and acceptability of specially designed assistive shoes in patients with PAD and to determine if there are any potential benefits of using these shoes over standard shoes. These assistive shoes may enable patients to carry out desired activities of daily living with less pain and more physical activity. Increasing physical activity will decrease morbidity and mortality. If proven beneficial, the findings will lead to a novel and conservative rehabilitation protocol that directly benefits Veterans nationwide.
The group in the trial
- Progressive improvement in walking performanceTreatment being tested
A total of ten patients with peripheral artery disease will be enrolled for this arm and wear the assistive tennis shoes for three-months as an intervention.
Treatment: Assistive tennis shoes
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Improving Walking in Peripheral Artery Disease Using Specially Designed Assistive Shoes
- Record updated
- 31 October 2025